Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 616, pseudogene** (RN7SL616P) is a human pseudogene belonging to the family of 7SL RNA-related sequences. 7SL RNA is normally the RNA component of the signal recognition particle (SRP), which plays essential roles in targeting proteins to the endoplasmic reticulum membrane, but RN7SL616P itself is a non-coding, probable processed pseudogene that does not encode a functional RNA or protein. The human genome contains hundreds of similar 7SL RNA-derived pseudogenes—these are truncated, nonfunctional sequences resulting from reverse transcription and genomic insertion of 7SL RNA[7][9]. As a pseudogene, RN7SL616P is not believed to participate directly in canonical biological signaling or disease pathways, nor is it a therapeutic target. Some pseudogenes have been shown to regulate gene expression through production of antisense transcripts or small interfering RNAs, but no specific regulatory or disease role has been reported for RN7SL616P[4][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 616, pseudogene (RN7SL616P).